Success Metrics

Completion Rate
0%(0/2)
Active Trials
2(25%)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
3
38%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Terminated(2)
Other(3)

Detailed Status

unknown3
Recruiting2
Terminated2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown338%
recruiting225%
terminated225%
not_yet_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
8